HIV drug resistance in persons initiating or reinitiating first-line antiretroviral therapy in Paraguay: Results of a National Patient Survey.

导出原文传递

翻译打印收藏纠错

第一作者： Gloria,Aguilar

第一单位： National Control Program for HIV/AIDS/STI, República del Paraguay Ministry of Public Health and Social Welfare, Asunción, Paraguay.

作者： Gloria,Aguilar ^[1] ; Hong-Ha M,Truong ^[2] ; Patricia,Ovelar ^[1] ; Tania,Samudio ^[1] ; Gladys,Lopez ^[1] ; Claudia,García-Morales ^[3] ; Daniela,Tapia-Trejo ^[3] ; Dulce M,López-Sánchez ^[3] ; Santiago,Ávila-Ríos ^[3] ; Amalia,Giron ^[4] ; Antonieta R,De Arias ^[5] ; Carlos,Rios-Gonzalez ^[6] ; Willi,McFarland ^[7]

作者单位： National Control Program for HIV/AIDS/STI, República del Paraguay Ministry of Public Health and Social Welfare, Asunción, Paraguay. ^[1] Department of Medicine, Center for Public Health Research, University of California, San Francisco, California, USA. ^[2] Centre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico. ^[3] Department of Global HIV, Hepatitis and STI Programmes, World Health Organization, Geneva, Switzerland. ^[4] Centro para el Desarrollo de la Investigación Científica, Asunción, Paraguay. ^[5] Direccion de Investigacion, Facultad de Ciencias Medicas, Universidad Nacional de Caaguazú, Coronel Oviedo, Paraguay. ^[6] Center for Public Health Research, San Francisco Department of Public Health, San Francisco, California, USA. ^[7]

关键词 HIV Paraguay antiretroviral therapy drug resistance late treatment initiation